Is Baidu Encyclopedia’s introduction to Cabozantinib authoritative and credible?

Baidu Encyclopedia is a widely used knowledge platform on the Chinese Internet. Its content is mainly written by users and published after being reviewed by the platform. For some popular drugs or medical terms, encyclopedia entries often cite public information, official news, scientific research papers or authoritative databases, but overall they are not uniformly written by a professional medical team, nor are they official explanations issued by medical institutions. This means that its content performs well in terms of popularity, but still has certain limitations in terms of professionalism and authority.

The current introduction to cabozantinib (Cabozantinib) on Baidu Encyclopedia basically covers its drug mechanism, indications, and targets (such asV EGFR, MET, AXL), applicable to kidney cancer, liver cancer, thyroid cancer and other information. Most of these contents are consistent with the information provided by international medical databases (such as FDA, EMA, ClinicalTrials.gov). Therefore, the content of Baidu Encyclopedia has certain reference value in terms of basic pharmacological knowledge and indications. However, it should be noted that some data may not be updated in real time, or lack more detailed information on different versions (such as original drugs and generic drugs), regional marketing status, etc.

Although Baidu Encyclopedia provides an easy-to-understand overview of drugs, because it is not a professional medical database and lacks authoritative sources, clinical guidance suggestions, and real-time update mechanisms, it is not suitable as the only basis for clinical medication or treatment decisions. Especially when it comes to dosage adjustment, adverse reaction treatment, medication contraindications, drug interactions, etc., the content is often brief or even missing, which can easily mislead patients or family members and affect treatment safety.

If you want to know professional information about cabozantinib, it is recommended that you first refer to the official website of the US FDA, the EMA Drug Information Database, the official website of the National Food and Drug Administration of China (NMPA) or drug instructions and other authoritative sources. At the same time, medical databases such as PubMed, UpToDate, ClinicalTrials.gov, etc. also provide detailed clinical research and safety data. For patients, communicating with professional oncologists, obtaining regular prescriptions, and choosing medications based on individual conditions are the keys to ensuring treatment effectiveness and safety. Baidu Encyclopedia can be used as a preliminary understanding tool, but should not replace professional medical advice.

Reference materials:https://www.drugs.com/